Page last updated: 2024-10-27

gabexate and Nephritis, Interstitial

gabexate has been researched along with Nephritis, Interstitial in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Nephritis, Interstitial: Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomita, N1
Kanamori, H1
Fujita, H1
Maruta, A1
Naitoh, A1
Nakamura, S1
Ota, Y1
Nozue, N1
Kihara, M1
Ishigatsubo, Y1

Other Studies

1 other study available for gabexate and Nephritis, Interstitial

ArticleYear
Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid.
    Anti-cancer drugs, 2001, Volume: 12, Issue:8

    Topics: Aged; Benzamidines; Dalteparin; Drug Administration Schedule; Gabexate; Guanidines; Humans; Idarubic

2001